Wohl & Fruchter LLP

Call Us 866-833-6245

  • About
  • Attorneys
  • Practice Areas
  • Cases
  • Results
  • News
  • Contact
  1. Home
  2. Cases
  3. Vital Energy

Vital Energy

We are investigating the fairness of the proposed sale of Vital Energy, Inc. (NYSE: VTLE) (“Vital”) to Crescent Energy Company (“Crescent”) pursuant to which Vital shareholders will receive 1.9062 shares of Crescent Class A common stock for each share of Vital common stock that they own.

Based on the stock price of Crescent of $9.47 per share as of 1:00 PM on August 25, 2025, the transaction implies a value of $18.05 per Vital share, which is well below the 52-week high for Vital of $38.02 per share, and thus suggests an opportunistic purchase.

Additionally, as further detailed below, several Vital shareholders have expressed disappointment in the deal price on SeekingAlpha.

If you remain a Vital shareholder and have concerns about the fairness of the proposed merger, you may contact our firm to discuss your legal rights at no charge by completing and submitting the form below.

Why is there an investigation?

On August 25, 2025, Vital announced that it had agreed to be sold to Crescent in a transaction under which Vital shareholders will receive 1.9062 shares of Crescent Class A common stock for each share of Vital common stock that they own.

Based on the stock price of Crescent of $9.47 per share as of 1:00 PM on August 25, 2025, the transaction implies a value of $18.05 per Vital share, which is well below the 52-week high for Vital of $38.02 per share, and thus suggests an opportunistic purchase.

Additionally, several Vital shareholders have expressed disappointment in the deal price on SeekingAlpha.

One Vital investor asserted: “I am a VTLE shareholder and I say “no way” to this proposal. VTLE BofD selling out the shareholders at such a low valuation.”

Another Vital investor lamented: “What a depressing display of value destruction here.”

“We are investigating whether the Vital Board of Directors acted in the best interests of Vital shareholders in approving the merger,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the exchange ratio agreed upon is fair to Vital shareholders, and whether all material information regarding the transaction has been fully disclosed.”

Contact Us About This Case

"*" indicates required fields

If you lost money, enter $ amount, and hit "tab" to verify. If you have a gain, enter $0.
Please check box*
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.
Click to Contact Us About This Case

Attorney

Joshua Fruchter
845-290-6818
alerts@wohlfruchter.com

  • Legal
  • Privacy Policy
  • Sitemap
  • Contact

Attorney Advertising. Prior results do not guarantee a similar outcome.

© 2025 Wohl & Fruchter LLP